This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Cooperative Agreement award for $997,142 aims to develop a rapid phenylalanine blood level monitor for patients with phenylketonuria (PKU), a lifelong genetic disorder. The product consists of a test strip and device that can provide frequent, accessible monitoring of phenylalanine levels from a finger prick to improve disease management and patient outcomes. The project focuses on optimizing the product design, manufacturing, and deployment to enable cost-effective access for end-users. This award, granted to the small business Omaroon Care on May 1, 2024, supports the advancement of this innovative medical device technology to address the significant healthcare challenges and costs associated with inadequate PKU monitoring.
Generated 1/28/25, 9:03 AM